摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲基-5-(4-甲基-1-哌嗪基)苯胺 | 1007211-93-9

中文名称
2-甲基-5-(4-甲基-1-哌嗪基)苯胺
中文别名
——
英文名称
2-methyl-5-(4-methylpiperazin-1-yl)aniline
英文别名
2-methyl-5-(4-methyl-piperazin-1-yl)-phenylamine;2-Methyl-5-(4-methylpiperazin-1-yl)benzenamine
2-甲基-5-(4-甲基-1-哌嗪基)苯胺化学式
CAS
1007211-93-9
化学式
C12H19N3
mdl
——
分子量
205.303
InChiKey
FCMGLBKFHTXSER-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    32.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • PYRIMIDINE DERIVATIVES AS PI3K INHIBITOR AND USE THEREOF
    申请人:Shimma Nobuo
    公开号:US20100069629A1
    公开(公告)日:2010-03-18
    A drug is provided that is useful as a preventive or therapeutic for cancer as a result of having superior PI3K inhibitory effects as well as superior stability in the body and water-solubility. A compound, or pharmaceutically acceptable salt thereof, represented by formula (I): [wherein, X represents a single bond, etc.; Y represents a single bond, etc. (provided that X and Y are not simultaneously single bonds); Z represents a hydrogen atom, etc.; m represents an integer of 1 or 2; and R 1 represents a cyclic substituent].
    提供了一种药物,由于具有优越的PI3K抑制作用以及在体内具有优越的稳定性和水溶性,因此可用作预防或治疗癌症。化合物或其药学上可接受的盐的表示式(I):[其中,X表示单键等;Y表示单键等(前提是X和Y不同时为单键);Z表示氢原子等;m表示1或2的整数;R1表示环状取代基]。
  • SUBSTITUTED DIHYDROPTERIDIN-6-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS
    申请人:Caruso Michele
    公开号:US20110053944A1
    公开(公告)日:2011-03-03
    Dihydropteridin-6-one derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    本发明揭示了式(I)中所定义的Dihydropteridin-6-one衍生物及其药学上可接受的盐,以及它们的制备方法和包含它们的制药组合物;本发明的化合物在治疗与蛋白激酶活性失调相关的疾病,如癌症方面可能有用。
  • SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS
    申请人:Caruso Michele
    公开号:US20100216808A1
    公开(公告)日:2010-08-26
    Pyrazolo-quinazoline derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    本发明揭示了式(I)中所定义的吡唑并喹唑啉衍生物及其药学上可接受的盐,以及它们的制备方法和包含它们的制药组合物;本发明中的化合物在治疗与蛋白激酶活性失调相关的疾病,如癌症中可能有用。
  • Pyrimidine derivatives as PI3K inhibitor and use thereof
    申请人:Chugai Seiyaku Kabushiki Kaisha
    公开号:US08022205B2
    公开(公告)日:2011-09-20
    A drug is provided that is useful as a preventive or therapeutic for cancer as a result of having superior PI3K inhibitory effects as well as superior stability in the body and water-solubility. A compound, or pharmaceutically acceptable salt thereof, represented by formula (I): [wherein, X represents a single bond, etc.; Y represents a single bond, etc. (provided that X and Y are not simultaneously single bonds); Z represents a hydrogen atom, etc.; m represents an integer of 1 or 2; and R1 represents a cyclic substituent].
    提供一种药物,由于具有卓越的PI3K抑制作用以及在体内具有卓越的稳定性和水溶性,因此可用作预防或治疗癌症。该化合物或其药学上可接受的盐的化学式为(I):[其中,X表示单键等;Y表示单键等(前提是X和Y不同时为单键);Z表示氢原子等;m表示1或2的整数;R1表示环状取代基]。
  • Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
    申请人:Caruso Michele
    公开号:US08598172B2
    公开(公告)日:2013-12-03
    Dihydropteridin-6-one derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    本发明公开了式(I)的二氢叶酸6-酮衍生物及其药学上可接受的盐,以及其制备方法和包含它们的药物组合物;本发明的化合物可能在治疗与蛋白激酶活性失调相关的疾病,如癌症方面有用。
查看更多